DOI QR코드

DOI QR Code

Monoclonal antibody-based enzyme-linked immunosorbent assay for quantification of majonoside R2 as an authentication marker for Nngoc Linh and Lai Chau ginsengs

  • Jiranan Chaingam (Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University) ;
  • Le Van Huy (Department of Biochemistry and Medicinal Chemistry, Research Institute for Biotechnology and Environment, Nong Lam University) ;
  • Kanta Noguchi (Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University) ;
  • Poomraphie Nuntawong (Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University) ;
  • Sornkanok Vimolmangkang (Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University) ;
  • Varalee Yodsurang (Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University) ;
  • Gorawit Yusakul (School of Pharmacy, Walailak University) ;
  • Satoshi Morimoto (Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University) ;
  • Seiichi Sakamoto (Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyushu University)
  • Received : 2024.02.05
  • Accepted : 2024.05.20
  • Published : 2024.09.01

Abstract

Background: Recent years have witnessed increasing interest in the high amount of ocotillol-type saponin in Panax vietnamensis, particularly in relation to majonoside R2 (MR2). This unique 3%-5% MR2 content impart Ngoc Linh and Lai Chau ginsengs with unique pharmacological activities. However, in the commercial domain, unauthentic species have infiltrated and significantly hindered access to the authentic, efficacious variety. Thus, suitable analytical techniques for distinguishing authentic Vietnamese ginseng species from others is becoming increasingly crucial. Therefore, MR2 is attracting considerable attention as a target requiring effective management measures. Methods: An enzyme-linked immunosorbent assay (ELISA) was developed by producing monoclonal antibodies against MR2 (mAb 16E11). The method was thoroughly validated, and the potential of the immunoassay was confirmed by high-performance liquid chromatography with ultraviolet spectroscopy. Furthermore, ELISA was applied to the assessment of the MR2 concentrations of various Panax spp., including Korean, American, and Japanese ginsengs. Results and conclusions: An icELISA using mAb 16E11 exhibited linearity between 3.91 and 250 ng/mL of MR2, with detection and quantification limits of 1.53 and 2.50 - 46.6 ng/mL, respectively. Based on this study, the developed icELISA using mAb 16E11 could be a valuable tool for analyzing MR2 level to distinguish authentic Ngoc Linh and Lai Chau ginsengs from unauthentic ones. Furthermore, the analysis of the samples demonstrated that Ngoc Linh and Lai Chau ginsengs exhibit a notably higher MR2 value than all other Panax spp. Thus, MR2 might be their ideal marker compound, and various bioactivities of this species should be explored.

Keywords

Acknowledgement

Dr. Le Van Huy would like to thank the financial support from the SAM VIET NHAT company for his work in this study.

References

  1. Hu Y, He Y, Niu Z, Shen T, Zhang J, Wang X, Hu W, Cho JY. A review of the immunomodulatory activities of polysaccharides isolated from Panax species. J Ginseng Res 2022;46:23-32.
  2. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen CJ. Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit 2004;10:187-92.
  3. Kim JH. Cardiovascular diseases and Panax ginseng: a review on molecular mechanisms and medical applications. J Ginseng Res 2012;36:16-26.
  4. Hou W, Wang Y, Zheng P, Cui R. Effects of ginseng on neurological disorders. Front Cell Neurosci 2020;14:55.
  5. Ong WY, Farooqui T, Koh HL, Farooqui AA, Ling EA. Protective effects of ginseng on neurological disorders. Front Aging Neurosci 2015;7:129.
  6. Christensen LP. Chapter 1 ginsenosides: chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 2008:1-99. Academic Press.
  7. Quang TP, Thi KHT, Ngoc BT, Dinh TP, Thanh TB, Thi HAN, Son NT, Son HT, Hung TT, Khuong NV. The ecology and saponins of Vietnamese ginseng-Panax vietnamensis var. fuscidiscus in north Vietnam. Asian J Agric Biol 2019;7:334-43.
  8. Thanh N, Van T, Lai H, Khiem N, Mai L, Xuyen D, Oanh PT, Hai DV, Dien ND, Tan ND. Bioactive compounds and biological activities of Vietnamese ginseng (Panax Vietnamensis Ha et Grushv.). In: Murthy HN, Paek KY, Park SY, editors. Bioactive compounds in the storage organs of plants. reference series in Phytochemistry. Cham: Springer; 2023. p. 1-25. https://doi.org/10.1007/978-3-031-29006-0_23-1.
  9. Decision number: 1247/QD-UBND. Author: The People's Committee of Kon Tum Province. Title of a government document: Decision for the management and use regulations of geographical indication Ngoc Linh for Ngoc Linh ginseng of Kon Tum Province. 2021. p. 1-11. Kon Tum Province, Vietnam. Year.
  10. Decision number: 3957/QD-UBND. Author: The People's Committee of Quang Nam Province. Title of a government document: Decision for the management and use regulations of the geographical indication Ngoc Linh. 2017. p. 1-19. Quang Nam Province, Vietnam. Year.
  11. Registration Certificate No. 00049. Name of government department: national Office of intellectual property. Title of a government document: Decision No. 2465/QD-SHTT on the amendment of geographical indication registration No. 00049 for Ngoc Linh ginseng. Place of publication: Industrial Property Official Gazette of Vietnam. 2018. p. 1135-9. ISSN 0868-2534. Number 366, Volume B (09.2018). Part VI: geographical indication registrations.
  12. Zhu S, Fushimi H, Cai S, Chen H, Komatsu K. A new variety of the genus Panax from southern Yunnan, China and its nucleotide sequences of 18S ribosomal RNA gene and matK gene. J Jap Bot 2003;78:86-94.
  13. Duy NV, Trieu LN, Chinh ND, Tran VT. A new variety of Panax (Araliaceae) from Lam vien plateau, Vietnam and its molecular evidence. Phytotaxa 2016;277:47-58.
  14. Phan K, Le T, Phan K, Vo D, Phan V. In Lai Chau ginseng Panax vietnamensis var. fuscidiscus K. Komatsu, S. Zhu & SQ Cai, I. morphology, ecology, distribution and conservation status, Proceedings of the 2nd VAST-KAST workshop on biodiversity and bioactive compounds, Hanoi, Vietnam, 2013; pp 65-73.
  15. Decision number: 1183/QD-UBND. Author: The People's Committee of Lai Chau Province. Title of government document: Decision for the management and use regulations of the trademark Sam Lai Chau. Edited by the People's Committee of Lai Chau Province, Vietnam. Edited place: Lai Chau Province. 2022. p. 1-17. Vietnam. Year.
  16. Trang NT, Mai NT, Zhuravlev YN. Application of DNA barcoding to authentic Panax vietnamensis. Am Sci Res J Eng Techno Sci 2017;29:60-7.
  17. Liu J, Xu Y, Yang J, Wang W, Zhang J, Zhang R, Meng Q. Discovery, semisynthesis, biological activities, and metabolism of ocotillol-type saponins. J Ginseng Res 2017;41:373-8.
  18. Tran QL, Adnyana IK, Tezuka Y, Nagaoka T, Tran QK, Kadota S. Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity. J Nat Prod 2001;64:456-61.
  19. Zhu S, Zou K, Cai S, Meselhy MR, Komatsu K. Simultaneous determination of triterpene saponins in ginseng drugs by high-performance liquid chromatography. Chem Pharm Bull 2004;52:995-8.
  20. Cao Y, Wang K, Xu S, Kong L, Bi Y, Li X. Recent advances in the semisynthesis, modifications and biological activities of ocotillol-type triterpenoids. Molecules 2020;25:55-62.
  21. Le QU, Lay HL, Wu MC, Thi HN, Duy-Lam N. Phytoconstituents and biological activities of Panax vietnamensis (Vietnamese ginseng): a precious ginseng and call for further research - a systematic review. Nat Prod Commun 2018;13:1381-4.
  22. Quan LT, Ketut AI, Yasuhiro T, Yuko H, Ikuo S, Youichi K, Qui KT, Shigetoshi K. Hepatoprotective effect of majonoside R2, the major saponin from Vietnamese ginseng (Panax vietnamensis). Planta Med 2002;68:402-6.
  23. Yamasaki K. Bioactive saponins in Vietnamese ginseng, Panax vietnamensis. Pharm Biol 2000;38:16-24.
  24. Duc NM, Nham NT, Kasai R, Ito A, Yamasaki K, Tanaka O. Saponins from Vietnamese ginseng, Panax vietnamensis HA et GRUSHV. collected in Central Vietnam. I. Chem Pharm Bull 1993;41:2010-4.
  25. Vu-Huynh KL, Nguyen HT, Van LTH, Ma CT, Lee GJ, Kwon SW, Park JH, Nguyen MD. Accumulation of saponins in underground parts of Panax vietnamensis at different ages analyzed by HPLC-UV/ELSD. Molecules 2020;25:3086.
  26. Zhu S, Zou K, Fushimi H, Cai S, Komatsu K. Comparative study on triterpene saponins of ginseng drugs. Planta Med 2004;70:666-77.
  27. Trieu LN, Duy NV, Tien TV. Genetic diversity of Panax vietnamensis var. langbianensis populations in Lamvien Plateau -Vietnam detected by inter simple sequence repeat (issr) markers. J Biotechnol 2019;17:651-61.
  28. Giang VNL, Waminal NE, Park HS, Kim NH, Jang W, Lee J, Yang TJ. Comprehensive comparative analysis of chloroplast genomes from seven Panax species and development of an authentication system based on species-unique single nucleotide polymorphism markers. J Ginseng Res 2020;44:135-44.
  29. Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009;7:293-302.
  30. Morita T, Kasai R, Tanaka O, Zhou J, Yang T, Shoji J. Saponins of Zu-Tziseng, rhizomes of Panax japonicus C. A. Meyer var. major (Burk.) C.Y. Wu et K. M. Fens collected in Yunnan, China. Chem Pham Bull 1982;30:4341-6.
  31. Tanaka K, Kubota M, Zhu S, Sankawa U, Komatsu K. Analysis of ginsenosides in ginseng drugs using liquid chromatography-fourier transform ion cyclotron resonance mass spectrometry. Nat Prod Commun 2007;2:625-32. gui.
  32. Nguyen HT, Vu-Huynh KL, Nguyen HM, Le HT, Le THV, Park JH, Nguyen MD. Evaluation of the saponin content in Panax vietnamensis acclimatized to Lam Dong province by HPLC-UV/CAD. Molecules 2021;26:5373.
  33. Van LTH, Lee SY, Kim TR, Kim JY, Kwon SW, Nguyen NK, Park JH, Nguyen MD. Processed Vietnamese ginseng: preliminary results in chemistry and biological activity. J Ginseng Res 2014;38:154-9.
  34. Sakamoto S, Putalun W, Vimolmangkang S, Phoolcharoen W, Shoyama Y, Tanaka H, Morimoto S. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. J Nat Med 2018;72:32-42.
  35. Sakamoto S, Yusakul G, Tsuneura Y, Putalun W, Usui K, Miyamoto T, Tanaka H, Morimoto S. Sodium periodate-mediated conjugation of harringtonine enabling the production of a highly specific monoclonal antibody, and the development of a sensitive quantitative analysis method. Analyst 2017;142:1140-8.
  36. Krittanai S, Pichetpongtorn P, Sakamoto S, Putalun W. Monoclonal antibody-based immunoassay for the specific quantification of licochalcone A: an active chalcone in licorice. Food Agric Immunol 2022;33:220-34.
  37. Noguchi K, Imahori D, Kido Y, Nuntawong P, Tanaka H, Morimoto S, Sakamoto S. Quality assessment method for Chinpi, dried Citrus spp. peel and its derived Kampo medicines using specific monoclonal antibody against hesperidin. Phytochem Anal 2023;34:652-60.
  38. Kitisripanya T, Krittanai S, Udomsin O, Jutathis K, Komaikul J, Juengwatanatrakul T, Sakamoto S, Tanaka H, Morimoto S, Putalun W. Development of an enzyme-linked immunosorbent assay for determination of miroestrol using an anti-miroestrol monoclonal antibody. Planta Med 2017;83:855-61.
  39. Khwanchuea R, Queiroz EF, Marston A, Jansakul C, Hostettmann K. Saponins from fresh fruits of Randia siamensis (lour) roem. & schult. (Rubiaceae). Nat Prod Commun 2008;3:163-70.
  40. Fuller S.A., Takahashi M., Hurrell J.G. Fusion of myeloma cells with immune spleen cells. Curr Protoc Biol 2001. Chapter 11; Unit 11.7.11.7.1-11.7.4.
  41. Fuller S.A., Takahashi M., Hurrell J.G. Cloning of hybridoma cell lines by limiting dilution. Curr Protoc Mol Biol 2001. [Chapter 11]: Unit 11.8.11.8.1-11.8.2.
  42. Vdovenko MM, Gribas AV, Vylegzhanina AV, Sakharov IY. Development of a chemiluminescent enzyme immunoassay for the determination of dexamethasone in milk. Anal Methods 2012;4:2550-4.
  43. Andreasson U, Perret-Liaudet A, Van LC, Blennow K, Chiasserini D, Engelborghs S, Fladby T, Genc S, Kluse N, Kuiperij HB, et al. A practical guide to immunoassay method validation. Front Neurol 2015;6:179-86.